Core Viewpoint - Junyao Health, known as the "first stock of lactic acid bacteria drinks," received a warning letter for failing to timely disclose its performance loss announcement, marking its first loss since going public in 2020 [2][5][10]. Financial Performance - In 2024, Junyao Health reported revenue of 1.458 billion yuan, a year-on-year decline of 10.77%, and a net profit loss of 29.12 million yuan, a year-on-year drop of 150.57% [7][10]. - The loss was primarily attributed to impairment provisions for goodwill (36.43 million yuan), inventory write-downs (12.76 million yuan), and credit impairment losses (36.60 million yuan) [8]. Stock Market Reaction - Despite the poor financial performance, Junyao Health's stock price surged, closing at 12.05 yuan per share on the first trading day after receiving the warning letter, marking a 10.05% increase and a new high for the year [2][13]. - Analysts suggest that the regulatory penalty has removed uncertainty, contributing to the stock's recovery, although there may be emotional or artificial factors influencing the price movements [6][13]. Executive Actions - During the stock price surge, several executives, including directors and supervisors, engaged in concentrated share sell-offs, totaling 383,400 shares and approximately 3.5373 million yuan in cash [4][15]. - The shareholding structure shows significant pledging, with the largest shareholder, Junyao Group, pledging about 151 million shares, accounting for 76.69% of its holdings and 25.11% of the total share capital [19][20].

证券代码：605388 证券简称：均瑶健康 公告编号：2025-034 湖北均瑶大健康饮品股份有限公司 关于召开 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 6 月 17 日（星期二）上午 10:00-11:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com） 会议召开方式：网络文字互动 投资者可于 6 月 16 日（星期一）16:00 前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱 juneyaodairy@juneyao.com 进行提问。公 司将在说明会上对投资者普遍关注的问题进行回答。 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）已于 2025 年 4 月 30 日发布《公司 2025 年第一季度报告》，为便于广大投资者更全面深入地了解 公司 2025 年第一季度经营成果、财务状况，公司计划于 2025 年 ...

Core Viewpoint - Hubei Junyao Health Beverage Co., Ltd. has been issued a warning letter by the Hubei Securities Regulatory Bureau for failing to disclose its 2024 performance forecast as required by regulations [1][5]. Group 1: Regulatory Actions - The company, along with its executives Wang Junhao, Yu Wei, Cui Peng, and Guo Qin, has been held primarily responsible for the violation of the Information Disclosure Management Measures for Listed Companies [5]. - The warning letter will be recorded in the securities and futures market integrity archives [5]. Group 2: Company Performance - In 2024, the company reported a net profit attributable to shareholders of -29.1164 million yuan, a decline of 150.57% year-on-year [6]. - The company's operating revenue for 2024 was 1.458 billion yuan, a decrease of 10.77% compared to the previous year [6]. - In the first quarter of the current year, the company achieved an operating revenue of 401 million yuan, a year-on-year increase of 1.41%, but the net profit attributable to shareholders decreased by 58.29% [6].

湖北均瑶大健康饮品股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任 重要内容提示： 证券代码：605388 证券简称：均瑶健康 公告编号：2025-033 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）股票于 2025 年 6 月 5 日、6 月 6 日、6 月 9 日连续 3 个交易日内收盘价格涨幅偏离值累计超过 20%。根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情 形。 经公司自查及向公司控股股东、实际控制人发函核实、确认，截至本公 告披露日，除公司已披露事项外，不存在其它应披露而未披露的重大事项。 请广大投资者理性投资，注意股票二级市场的交易风险。 一、股票交易异常波动的具体情况 公司股票于 2025 年 6 月 5 日、6 月 6 日、6 月 9 日连续 3 个交易日内收盘 价格涨幅偏离值累计超过 20%。根据《上海证券交易所交易规则》的有关规定， 属于股票交易异常波动情形。 二、公司关注并核实的相关情况 （一）生产经营情况 1 经公司自查，公司目前生产经营活动正 ...

Investment Rating - The report maintains a "Recommendation" rating for the food and beverage industry, indicating that the industry index is expected to outperform the benchmark index by more than 10% [5]. Core Insights - The food and beverage sector in A-shares has seen a decline of 2.12% over the past two weeks, underperforming the Shanghai Composite Index by 3.22 percentage points [2][14]. - Within the sector, soft drinks (+9.45%), snacks (+5.48%), and other alcoholic beverages (+4.98%) have shown the highest gains, while dairy products (-3.81%), liquor (-3.64%), and fermented seasoning products (-1.26%) have experienced the largest declines [2][14]. - Notable individual stock performances include Junyao Health (+72.44%), Hainan Coconut Island (+20.26%), and Miaokelando (+19.95%) leading in gains, while Wufangzhai (-10.35%), ST Jiajia (-6.92%), and Shanxi Fenjiu (-5.41%) faced the largest losses [2][14]. Summary by Sections Market Review - The food and beverage industry in A-shares has underperformed compared to major indices, with a year-to-date decline of 2.57% [14]. - The report highlights the performance of various sub-sectors, with soft drinks and snacks showing resilience while liquor and dairy face challenges [2][14]. Key Data Tracking - The report provides pricing data for key products, such as the price of Feitian Moutai at 2,130 RMB for original boxes and 2,050 RMB for bulk, reflecting a decrease of 25 RMB and 50 RMB respectively over two weeks [3][29]. - The average price of fresh milk in major production areas is reported at 3.06 RMB per kilogram, down 8.4% year-on-year [36]. Key Events Tracking - The report notes that the food manufacturing sector's profit increased by 1.1% year-on-year in the first four months of 2025, with total revenue reaching 713.58 billion RMB [4][55]. - Performance in the e-commerce space during the Tmall 618 event shows strong sales for brands like Three Squirrels and Good Products Store [4][55]. Investment Recommendations - For the liquor segment, the report suggests focusing on high-end brands with strong market positions, such as Guizhou Moutai and Wuliangye, while also considering regional leaders with favorable competitive dynamics [10][56]. - In the broader consumer goods category, the report highlights the rising popularity of yellow wine and the seasonal uptick in beer consumption, alongside strong performance in snack foods and energy drinks [10][56].

智通财经6月9日电，均瑶健康(605388.SH)发布异动公告，公司于2025年2月28日披露了《湖北均瑶大健 康饮品股份有限公司部分董监高集中竞价减持股份计划公告》。公司监事陈艳秋于本次股票交易异常波 动期间内即2025年6月6日根据减持计划减持了5700股公司股票。经公司核实，公司控股股东、实际控制 人及其一致行动人，以及公司其他董事、监事、高级管理人员在公司本次股票交易异常波动期间不存在 买卖公司股票的情况。 均瑶健康：监事陈艳秋于6月6日根据减持计划减持了5700股公司股票 ...

Core Viewpoint - Junyao Health, known as the "first stock of ambient lactic acid bacteria," has recently faced penalties for failing to timely announce a profit warning for its 2024 annual performance, marking its first annual loss since its listing in 2020 [1][4][5]. Financial Performance - In 2024, Junyao Health reported a revenue of 1.458 billion yuan, a year-on-year decline of 10.77% [6]. - The company recorded a net profit loss attributable to shareholders of 29.1164 million yuan for 2024, primarily due to impairment provisions totaling 3.643 million yuan for goodwill, 1.276 million yuan for inventory, and 3.660 million yuan for credit losses [4][5]. - In the first quarter of 2025, the company achieved a revenue of 401 million yuan, a year-on-year increase of 1.41%, but the net profit attributable to shareholders decreased by 58.29% to 10.91 million yuan [6]. Stock Performance - Despite the poor financial performance, Junyao Health's stock price surged over 70% in less than two weeks, from 6.35 yuan per share to 10.95 yuan per share [2][7]. Business Strategy and Challenges - The company has been diversifying into new business areas such as bottled water, probiotics, and supply chain management, but these efforts have not yet yielded significant results [9][11]. - The probiotics segment, which is a key focus for the company, has faced challenges including low industry entry barriers, intense price competition, and changing consumer preferences towards low-sugar products [10]. - The supply chain business, acquired in 2022, failed to meet its revenue and profit commitments, contributing to the company's financial difficulties [11].

警示函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605388 证券简称：均瑶健康 公告编号：2025-032 湖北均瑶大健康饮品股份有限公司 关于公司及相关责任人收到湖北证监局 （证监会令第 182 号）第四条、第五十一条第二款和第三款的规定履行勤勉尽 责义务，对公司上述违规行为负有主要责任。 根据《上市公司信息披露管理办法》（证监会令第 182 号）第五十二条的规 定，我局决定对湖北均瑶大健康饮品股份有限公司、王均豪、俞巍、崔鹏、郭沁 采取出具警示函的行政监管措施，并记入证券期货市场诚信档案。公司及相关责 任人应充分吸取教训，加强证券法律法规学习，杜绝此类行为再次发生。 如果对本监督管理措施不服，可以在收到本决定书之日起 60 日内向中国证 券监督管理委员会提出行政复议申请；也可以在收到本决定书之日起 6 个月内向 有管辖权的人民法院提起诉讼。复议与诉讼期间，上述监督管理措施不停止执 行。" 二、相关情况说明 湖北均瑶大健康饮品股份有限公司（以下简称"公司"）近日收到中国证券 监督管理委员会湖北监管局 ...

均瑶健康（605388）公告，公司近日收到湖北证监局下发的《警示函》，指出公司存在未按规定披露 2024年度业绩预告的违规事实。2024年归属于上市公司股东净利润为-2911.64万元。公司董事长王均 豪、总经理俞巍、财务总监崔鹏、董事会秘书郭沁因未履行勤勉尽责义务，对违规行为负有主要责任。 湖北证监局决定对公司及相关责任人采取出具警示函的行政监管措施，并记入证券期货市场诚信档案。 公司及相关责任人将加强证券法律法规学习，提高规范意识，避免类似问题再次发生。本次行政监管措 施不会影响公司正常的生产经营活动。 ...

Group 1 - The dairy sector experienced a decline of 1.44% as of the market close on June 6, ranking among the top losers in the concept sector [1][2] - Major companies within the dairy sector that saw significant declines include Lihua Foods, New Dairy, and Happy Family, while the top gainers were Junyao Health, *ST Tianshan, and Jinjian Rice Industry, with increases of 5.80%, 1.99%, and 0.59% respectively [1][2] - The dairy sector faced a net outflow of 379 million yuan from main funds today, with 25 stocks experiencing net outflows, and 13 stocks seeing outflows exceeding 10 million yuan [2][3] Group 2 - The stock with the highest net outflow was Yili Group, which saw a net outflow of 114 million yuan, followed by Junyao Health, Bei Yin Mei, and Yiya Tong with outflows of 53.44 million yuan, 40.58 million yuan, and 36.65 million yuan respectively [2][3] - Conversely, the stocks with the highest net inflows included Jinjian Rice Industry, Guangming Dairy, and Weivi Co., with net inflows of 15.03 million yuan, 11.77 million yuan, and 6.89 million yuan respectively [2][3] - The dairy sector's outflow list highlighted Yili Group with a decline of 1.10%, Junyao Health with an increase of 5.80%, and Bei Yin Mei with a decline of 1.78% [3]